Insider Transactions and Holdings
-
Entity Type
-
Individual
-
Role
-
Chief Medical Officer
-
Stock Symbol
-
PASG on Nasdaq
Mark S. Forman - trading volume in the past year for Passage BIO, Inc.
Holdings reported by Mark S. Forman for Passage BIO, Inc.
| Class |
Num Shares |
Value |
Price $ |
Transaction Date |
Ownership |
Underlying Class |
Underlying Amount |
| Common Stock |
48.6K |
$47.2K |
$0.97 |
Feb 13, 2024 |
Direct |
|
|
| Restricted Stock Unit |
10K |
$9.1K |
$0.91 |
Feb 10, 2024 |
Direct |
Common Stock |
|
| Employee Stock Option (right to buy) |
203K |
|
|
Mar 15, 2024 |
Direct |
Common Stock |
|
Transactions reported by Mark S. Forman for Passage BIO, Inc.
| Sym |
Class |
Transaction |
% |
Value $ |
* Price $ |
Shares |
Shares After |
Date |
Ownership |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.